Article
“Tumor-to-endothelium mitochondrial transfer licenses endothelial cells for CD8 <sup>+</sup> T cell recognition via mitochondrial neoantigen presentation”
2026-02-02
Abstract excerpt
Renal cell carcinoma (RCC) frequently exhibits resistance to immune checkpoint blockade, highlighting the need for strategies that enhance tumor-specific T cell priming and improve immune access to the tumor microenvironment. Here we show that vaccination targeting tumor-associated mitochondrial antigens (TAMAs), derived from tumor-specific mitochondrial DNA (mtDNA) missense mutations, synergizes with PD-1/PD-L1 b...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6f5ff1d8-8759-5452-a824-1e46ab19ba23
- DOI
- 10.64898/2026.01.30.702567
